Prostate-Specific Antigen (PSA) Testing Market Size, Opportunities, Key Growth Factors, Revenue Analysis, For 2022–2027

PSA or Prostate-specific antigen test measures the level of PSA in human blood. The prostate is a small gland located below the bladder of a man's reproductive system


Reports and Data has recently published  a new report on the Global Prostate-Specific Antigen (PSA) Testing Market that offers key insights into the current and emerging trends, key companies and market size and market share on a global and regional level. Despite weak development in Western economies as a whole, MA (mergers and acquisitions) activity in the healthcare sector has increased dramatically. Not only is there a strong growth in pharmaceutical companies, but also considerable growth in economies of emerging markets. 

These findings are detailed in Reports and Data Global Prostate-Specific Antigen (PSA) Testing Market Report, which indicates that the medicines industry has a promising future. According to RnD, the global Prostate-Specific Antigen (PSA) Testing Market is expected to reach USD XX billion in 2027 at a CAGR of XX% during the forecast period of 2022-2027. Market consolidation in Western Europe and North America is to blame for the growth in deal valuations. North America led the way in terms of acquisitions last year, accounting for over half of all outbound deals. 

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ 

Now that the tide is turning, more worldwide growth in the pharmaceutical business is likely to come from emerging nations, particularly China, where health systems are rapidly developing. Despite the fact that only a few acquisitions were announced or completed, tremendous growth is projected in the future years. 

Significantly, China's adoption of health insurance and broader healthcare reforms last year effectively created a market of one billion people overnight. However, generic medications account for 76% of the Chinese market, making it difficult for European and American multinationals to capitalize on market prospects. 

In the past, developed countries were hesitant to trade in emerging markets, with only a few multinational pharmaceutical companies making acquisitions in Latin America, India, or China. However, with tremendous development potential in the East, major businesses in the pharmaceutical industry should explore acquisitions in China aggressively to gain a presence.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ 

The entry of startups and regional players in the recent years and their increasing focus on drug development and research and advancements in therapeutics and medical devices are also expected to contribute to the growth of the market. 

Among the product types, the demand for personalized medicine for cancer is expected to dominate other types over the forecast period attributing to growing demand for customized therapies to treat various types of cancer and growing incidence of cancer globally. 

The report is a compilation of detailed market overview based on mergers-acquisitions, collaborations and trends and opportunities. Some of the prominent players of the prostate-specific antigen testing market are:

  • Abbott
  • Siemens Healthcare
  • DiaSorin
  • Roche
  • Beckman Coulter
  • Mediwatch (LABORIE)
  • BodiTech
  • Bristol-Myers Squibb Company
  • GE Healthcare
  • Endocare
  • GlaxoSmithKline
  • Anixa Biosciences
  • Ortho Clinical
  • Fujirebio
  • Pharmacia Delfia

Regional Analysis Cover

  • North America 
  • Europe 
  • Asia Pacific  
  • Latin America  
  • Middle East Africa  

Highlights of the Report

  • A comprehensive overview of the prostate-specific antigen testing market with the market size, market share, cost structure and estimation of revenue generation for the forecast period. 
  • In-depth analysis and methodologies of the global and regional scope of the market. 
  • Extensive analysis of, future trends, restraints, market drivers, challenges, limitations, and risks.
  • A thorough analysis of key players in the market and the company business profiles and product new launches and portfolios to provide a better scope of the competitive landscape.
  • Strategic recommendations for market players and new entrants and current exist to gain a robust footing in the market.

Prostate-Specific Antigen (PSA) Testing Market Segmentation

By Types (Revenue, USD Million; 2017–2027)

  • CLIA Method
  • ELISA Method

By Applications (Revenue, USD Million; 2017–2027)

  • Screening
  • Post-treatment monitoring
  • Others

Growing advancements in medical therapies to drive market growth 

The pharmaceutical and healthcare industry is driven by rapid advancements in customized therapies, medical devices, and surgical procedures. Integration of advanced technologies to accelerate research and development and manufacturing and production activities are some other factors driving market growth. 

High prices of certain drugs might affect revenue growth 

Launch of high-priced drugs to treat rare and chronic diseases and lesser affordability in middle- and low-income regions might limit their adoption and restrain market growth going ahead. In addition, less knowledge and awareness regarding advanced treatment approaches and lower adoption of advanced technologies might further hamper market growth over the forecast period. 

Request a customization of the report @ 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W, Head of Business Development

Reports And Data | Web:

Direct Line: +1-212-710-1370


LinkedIn | Twitter | Blogs

Read the innovative blog at

Check out our upcoming research report at

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: